El-Serag Hashem B, Graham David Y, Rabeneck Linda, Avid Adjula, Richardson Peter, Genta Robert M
Section of Gastroenterology, Houston Department of Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, USA.
Scand J Gastroenterol. 2007 Oct;42(10):1158-66. doi: 10.1080/00365520701299915.
The findings of studies examining the prevalence and major risk factors of histological abnormalities of the gastric cardia have been inconsistent. Selection bias was possible in these studies depending on whether patients were referred for ulcer or gastroesophageal reflux disease (GERD). There have been no studies on non-patient populations. The aim of this study was to mitigate the potential effects of selection bias.
In a study comprising health-care workers, we distributed symptom questionnaires and invitations to undergo upper endoscopy. A single endoscopist performed standard endoscopy and biopsy examinations (2 antral, 2 corporal, and 2 cardiac biopsies). Staining was done using triple stain. Two pathologists, who were blinded to the results of the questionnaires and endoscopy, interpreted and recorded the histological findings.
A total of 226 participants underwent endoscopy. Gastric cardia, as defined by the presence of mucous glands, was identified in 191 subjects; mean age of the subjects was 45 years, 117 (61%) were women, and 49% were black. Active gastritis of the cardia was present in 58 (30.4%), chronic gastritis in 133 (69.6%), intestinal metaplasia (IM) in 29 (15.2%), and pancreatic metaplasia in 25 (13%). Direct (organisms) or indirect evidence (active anywhere or chronic gastritis in antrum or corpus) for Helicobacter pylori was present in all participants with active gastritis, 60% of subjects with chronic gastritis, and approximately half of those with IM of the cardia. Approximately 15% with chronic carditis had neither H. pylori nor GERD symptoms. There were also no significant differences in the prevalence of heartburn or acid regurgitation, or the use of histamine-2-receptor antagonists (H2RAs) or proton-pump inhibitors (PPIs) between groups with and without active or chronic gastritis, IM, or pancreatic metaplasia, whereas active or chronic gastritis in the antrum or corpus and H. pylori infection were more frequent (1.5- to 2-fold) among those with histological abnormalities of the cardia.
Active and chronic gastritis as well as intestinal metaplasia of the gastric cardia are relatively common in health-care worker volunteers. Although GERD symptoms are not significantly associated with these abnormalities, H. pylori infection is a strong risk factor. However, a considerable number of participants with chronic gastritis of the cardia have neither H. pylori nor GERD.
关于贲门组织学异常的患病率及主要危险因素的研究结果并不一致。这些研究可能存在选择偏倚,取决于患者是因溃疡还是胃食管反流病(GERD)而被转诊。尚无针对非患者人群的研究。本研究的目的是减轻选择偏倚的潜在影响。
在一项针对医护人员的研究中,我们发放了症状问卷并邀请他们接受上消化道内镜检查。由一名内镜医师进行标准的内镜检查和活检(2块胃窦、2块胃体和2块贲门活检)。采用三联染色法进行染色。两名病理学家在不知道问卷和内镜检查结果的情况下,对组织学结果进行解读和记录。
共有226名参与者接受了内镜检查。在191名受试者中发现了有黏液腺的贲门;受试者的平均年龄为45岁,117名(61%)为女性,49%为黑人。贲门活动性胃炎患者有58名(30.4%),慢性胃炎患者有133名(69.6%),肠化生(IM)患者有29名(15.2%),胰腺化生患者有25名(13%)。所有活动性胃炎参与者、60%的慢性胃炎患者以及大约一半的贲门IM患者都有幽门螺杆菌的直接(微生物)或间接证据(胃窦或胃体任何部位的活动性或慢性胃炎)。约15%的慢性贲门炎患者既没有幽门螺杆菌感染也没有GERD症状。在有或没有活动性或慢性胃炎、IM或胰腺化生的组之间,烧心或反酸的患病率、组胺-2受体拮抗剂(H2RAs)或质子泵抑制剂(PPIs)的使用情况也没有显著差异,而在贲门组织学异常的患者中,胃窦或胃体的活动性或慢性胃炎以及幽门螺杆菌感染更为常见(1.5至2倍)。
在医护人员志愿者中,贲门的活动性和慢性胃炎以及肠化生相对常见。虽然GERD症状与这些异常没有显著关联,但幽门螺杆菌感染是一个很强的危险因素。然而,相当一部分贲门慢性胃炎患者既没有幽门螺杆菌感染也没有GERD。